Not yet recruitingPhase 3NCT06837597
Jianzhong Qushi in Chronic RRI
Studying Radiation proctitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Principal Investigator
- Li Feng, MD.Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Intervention
- Jianzhong Qushi Formula(drug)
- Enrollment
- 168 target
- Eligibility
- 18-85 years · All sexes
- Timeline
- 2025 – 2029
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06837597 on ClinicalTrials.govOther trials for Radiation proctitis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07378631Association Between Clinical Subtypes and Prognosis in Radiation Rectal InjurySixth Affiliated Hospital, Sun Yat-sen University
- RECRUITINGPHASE2NCT06776029Fecal Microbiota Transplantation for Radiation-Induced ProctopathySixth Affiliated Hospital, Sun Yat-sen University
- RECRUITINGPHASE2NCT06776016Dietary Supplements to Treat Radiation-Induced Rectal InjurySixth Affiliated Hospital, Sun Yat-sen University
- ENROLLING BY INVITATIONPHASE1, PHASE2NCT06974123A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of Oral Teslanbaicin in Patients With Radiation ProctitisThe First Affiliated Hospital of Xinxiang Medical College
- ACTIVE NOT RECRUITINGNANCT06087718Feasibility of the Maastro Applicator in Rectal CancerMaastricht Radiation Oncology
- RECRUITINGPHASE1, PHASE2NCT06438809Umbilical-Cord-Derived Mesenchymal Stem Cells Injection for Chronic Radiation ProctitisJiangsu Topcel-KH Pharmaceutical Co., Ltd.